We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
URGN icon
1
UroGen Pharma
URGN
$1.99B
$1.99B $40.78 0.46%
ADMA icon
2
ADMA Biologics
ADMA
$1.97B
$1.97B $8.48 2.54%
ASTH icon
3
Astrana Health
ASTH
$1.96B
$1.96B $39.59 1.79%
GLUE icon
4
Monte Rosa Therapeutics
GLUE
$1.93B
$1.93B $22.86 0.35%
GHRS icon
5
GH Research
GHRS
$1.92B
$1.92B $27.96 2.49%
HCM icon
6
HUTCHMED
HCM
$1.91B
$1.91B $11.13 1.09%
CDNA icon
7
CareDx
CDNA
$1.91B
$1.91B $37.01 0.35%
OCUL icon
8
Ocular Therapeutix
OCUL
$1.9B
$1.9B $8.69 2.12%
MESO
9
Mesoblast
MESO
$1.9B
$1.9B $14.66 4.25%
UFPT icon
10
UFP Technologies
UFPT
$1.89B
$1.89B $244.44 3.05%
TYRA icon
11
Tyra Biosciences
TYRA
$1.88B
$1.88B $31.65 3.33%
OMCL icon
12
Omnicell
OMCL
$1.87B
$1.87B $41.08 0.2%
BCAX
13
Bicara Therapeutics
BCAX
$1.87B
$1.87B $28.43 5.22%
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.86B
$1.86B $21 0.91%
KARD
15
Kardigan Inc
KARD
$1.86B
$1.86B $20.82 0.39%
ATRC icon
16
AtriCure
ATRC
$1.85B
$1.85B $36.57 4.37%
FTRE icon
17
Fortrea Holdings
FTRE
$1.85B
$1.85B $19.54 0.1%
DMRA
18
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$1.84B $29.92 3.82%
LKFT
19
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1.84B $28.12 1.01%
STOK icon
20
Stoke Therapeutics
STOK
$1.84B
$1.84B $29.56 0.89%
BFLY icon
21
Butterfly Network
BFLY
$1.81B
$1.81B $6.93 5.32%
ANIP icon
22
ANI Pharmaceuticals
ANIP
$1.78B
$1.78B $78.45 1.03%
IMCR icon
23
Immunocore
IMCR
$1.78B
$1.78B $35.06 0.17%
AAPG
24
Ascentage Pharma
AAPG
$1.77B
$1.77B $19 3.88%
WGS icon
25
GeneDx Holdings
WGS
$1.77B
$1.77B $59.58 0.81%
1
2 3 4 5

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 304 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $265B.

The largest by market cap are UroGen Pharma (URGN) at $1.99B, ADMA Biologics (ADMA) at $1.97B and Astrana Health (ASTH) at $1.96B.

Among institutional investors, Aktis Oncology (AKTS) drew the most net new fund positions in Q1 2026: 69 funds opened new positions.

  • Combined market cap: $265B across 304 stocks.
  • Small Cap: market cap between $250M and $2B.
  • Largest constituent: UroGen Pharma (URGN), $1.99B market cap.
  • Most net new fund positions in Q1 2026: Aktis Oncology (AKTS), +69 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.